Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Medical Imaging and Radiation Sciences
|
May 5, 2019
Maltese Radiographers' Attitudes towards Continuing Professional Development: An Initial Study Using Concept Maps
Joseph Castillo, Carmel J Caruana
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru
|
February 21, 2018
[Concurrent lymphocytic colitis and microscopic enteritis in patients with chronic diarrhea]
Fernando Arévalo, Greys Vergara, Susy Ruiz, et al.
Blood
|
July 3, 2013
Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation
Jing Lu, Tatiana Zavorotinskaya, Yumin Dai, et al.
The Journal of Molecular Diagnostics : JMD
|
October 17, 2021
Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion Detection
Christina Bormann Chung, Jeeyun Lee, Marc Barritault, et al.
Molecular Cancer Therapeutics
|
November 8, 2014
Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer
Melissa R Junttila, Vidusha Devasthali, Jason H Cheng, et al.
Cancer Immunology Research
|
April 24, 2020
Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer
Marie-Claire Wagle, Joseph Castillo, Shrividhya Srinivasan, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors
Matthew T Burger, Wooseok Han, Jiong Lan, et al.
Cancer Research
|
June 12, 2019
CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms
Joseph Castillo, Esther Wu, Christopher Lowe, et al.
Journal of Medicinal Chemistry
|
October 28, 2015
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies
Matthew T Burger, Gisele Nishiguchi, Wooseok Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2014
Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancers
Pablo D Garcia, John L Langowski, Yingyun Wang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Medical Imaging and Radiation Sciences
|
May 5, 2019
Maltese Radiographers' Attitudes towards Continuing Professional Development: An Initial Study Using Concept Maps
Joseph Castillo, Carmel J Caruana
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru
|
February 21, 2018
[Concurrent lymphocytic colitis and microscopic enteritis in patients with chronic diarrhea]
Fernando Arévalo, Greys Vergara, Susy Ruiz, et al.
Blood
|
July 3, 2013
Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation
Jing Lu, Tatiana Zavorotinskaya, Yumin Dai, et al.
The Journal of Molecular Diagnostics : JMD
|
October 17, 2021
Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion Detection
Christina Bormann Chung, Jeeyun Lee, Marc Barritault, et al.
Molecular Cancer Therapeutics
|
November 8, 2014
Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer
Melissa R Junttila, Vidusha Devasthali, Jason H Cheng, et al.
Cancer Immunology Research
|
April 24, 2020
Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer
Marie-Claire Wagle, Joseph Castillo, Shrividhya Srinivasan, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors
Matthew T Burger, Wooseok Han, Jiong Lan, et al.
Cancer Research
|
June 12, 2019
CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms
Joseph Castillo, Esther Wu, Christopher Lowe, et al.
Journal of Medicinal Chemistry
|
October 28, 2015
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies
Matthew T Burger, Gisele Nishiguchi, Wooseok Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2014
Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancers
Pablo D Garcia, John L Langowski, Yingyun Wang, et al.
Page
of 1